| EMA number | EMEA/H/C/000562 |
| ATC code | B01AE06 |
| Authorisation | 20 September 2004 |
| Withdrawn | 21 June 2018 |
| Revision | 22 |
Angiox is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (PCI), including patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary PCI. Angiox is also indicated for the treatment of adult patients with unstable angina / non-ST-segment-elevation myocardial infarction (UA / NSTEMI) planned for urgent or early intervention. Angiox should be administered with aspirin and clopidogrel.